Inactive Instrument

Highlights Accelerate Diagnostics Inc NYSE

Stocks

US0043042003

Investment Holding Companies

End-of-day quote NYSE Other stock markets
- ^USD	-

25-09-15	AST Revolution, LLC acquired Accelerate WAVE and Arc Systems of AST Revolution, LLC	CI
25-08-20	Accelerate Diagnostics, Inc. Went Out of Business	CI

Highlights

25-09-15	AST Revolution, LLC acquired Accelerate WAVE and Arc Systems of AST Revolution, LLC	CI
25-06-03	Indaba Starling, LLC entered into a term sheet to acquire Accelerate Diagnostics B.v, Accelerate Diagnostics Sl, Accelerate Diagnostics S.R.L, Accelerate Diagnostics GmbH and Accelerate Diagnostics Pty Ltd from Accelerate Diagnostics Texas, LLC and Accelerate Diagnostics, Inc. (OTCPK:AXDX.Q).	CI
25-05-07	Motion for Asset Sale Filed by Accelerate Diagnostics, Inc.	CI
25-03-21	Accelerate Diagnostics Submits WAVE System and Gram-Negative Positive Blood Culture Menu to the FDA for 510(k) Clearance	CI
25-03-21	Accelerate Diagnostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
24-11-07	Accelerate Diagnostics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
24-11-07	Earnings Flash (AXDX) ACCELERATE DIAGNOSTICS Reports Q3 Revenue $3M	MT
24-09-30	Accelerate Diagnostics, Inc. Announces FDA Clearance of its Accelerate Arc?? System	CI
24-08-08	Earnings Flash (AXDX) ACCELERATE DIAGNOSTICS Reports Q2 Revenue $3M	MT
24-08-08	Accelerate Diagnostics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
24-08-08	Accelerate Diagnostics, Inc. Announces Successful Completion of Its Wave Pre-Clinical Trial	CI
24-05-08	Earnings Flash (AXDX) ACCELERATE DIAGNOSTICS Reports Q1 Revenue $2.9M, vs. Street Est of $3M	MT
24-05-08	Accelerate Diagnostics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
24-03-29	Accelerate Diagnostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
23-11-27	Accelerate Diagnostics Announces Collaboration for the Use of the Arc System in Combination With Bruker´s MALDI Biotyper	CI
23-11-09	Accelerate Diagnostics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
23-11-09	Earnings Flash (AXDX) ACCELERATE DIAGNOSTICS Posts Q3 Revenue $3.3M	MT
23-08-10	Earnings Flash (AXDX) ACCELERATE DIAGNOSTICS Reports Q2 Revenue $2.9M	MT
23-08-10	Accelerate Diagnostics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
23-05-11	Earnings Flash (AXDX) ACCELERATE DIAGNOSTICS Posts Q1 Revenue $2.8M	MT
23-05-11	Accelerate Diagnostics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
23-03-29	Accelerate Diagnostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	CI
22-12-19	Accelerate Diagnostics Files Application With US FDA to Update PhenoTest BC Kit	MT
22-12-19	Accelerate Diagnostics Submits 510(K) Application to FDA for Gram-Negative Menu Expansion and Breakpoint Updates for the Accelerate Phenotest(R) BC Kit	CI
22-11-14	Accelerate Diagnostics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	CI